Posted 28th November 2018 by Jane Williams
It was a pleasure to have Dirk Gevers involved in our Microbiome Futures project earlier this year. In the following opinion piece, Dirk reflects on the outcomes that went on to be published in Nature Biotechnology.
The original article can be found on Biovox and is republished here with kind permission.
Posted 9th November 2018 by Jane Williams
In May of this year, Nature Biotechnology and Global Engage convened a panel of leaders in the microbiome field that included CEOs and CSOs of several microbiome companies, representatives from big pharmas working in the space, and top academics from the New York area and beyond to discuss the current state of the art in human microbiome research and its translation into therapies.
Posted 19th October 2018 by Jane Williams
We spoke to Lindsay Kalan, from the University of Wisconsin-Madison about wound healing, the similarities between gut and skin microbiome and what the future holds for the development of new therapies.
Posted 15th October 2018 by Jane Williams
Acne is the most common skin condition in the USA, affecting 85% of the world’s population over their lifetime and approximately 50 million people in the USA each year.
Posted 8th October 2018 by Jane Williams
Over recent years, we have seen record numbers of skin cancer diagnoses around the world. Indeed, since the 1980s, incidences of melanoma, the deadliest form of cancer, have doubled. Melanoma is an aggressive form of cancer that can spread to other organs and is estimated it will kill 10,000 people in the US this year. Approximately 3 million Americans will be diagnosed with skin cancer this year in the US.
Posted 14th September 2018 by Jane Williams
As diet and the microbiome are closely entwined, the first step in understanding a healthy infant gut microbiome is to understand a healthy infant diet. Fortunately, a healthy infant diet is at least superficially simple to define, exclusive breastfeeding for the first six months is the best nutrition for infants according to the World Health Organisation. A common alternative to human breast milk for infants is formula and the microbiomes of breastfed and formula fed infants are known to differ.
Posted 7th September 2018 by Jane Williams
Antibiotic use can disrupt your body’s protective microbial barrier and open the door to pathogens and illness. Our research focuses on developing next-generation probiotics that would selectively prevent infection by the bacterium Clostridium difficile, a gastrointestinal pathogen that produces toxins resulting in watery diarrhoea and in severe cases, pseudomembrane colitis, toxemia, sepsis and death.
Posted 3rd August 2018 by Jane Williams
Human skin is the largest organ that acts as a front line of defence against toxic effects from its exposure to toxic environmental factors1-3. Skin Microbiome is considered an integral part of skin barrier that, combined with innate immunity, plays a key role in maintaining the skin health4-7.